| Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD F Lavorini, A Magnan, JC Dubus, T Voshaar, L Corbetta, M Broeders, ... Respiratory medicine 102 (4), 593-604, 2008 | 825 | 2008 |
| Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci, ... The Journal of clinical investigation 130 (9), 4694-4703, 2020 | 508 | 2020 |
| Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes OS Usmani, F Lavorini, J Marshall, WCN Dunlop, L Heron, E Farrington, ... Respiratory research 19, 1-20, 2018 | 377 | 2018 |
| Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes DB Price, M Román-Rodríguez, RB McQueen, S Bosnic-Anticevich, ... The Journal of Allergy and Clinical Immunology: In Practice 5 (4), 1071-1081. e9, 2017 | 360 | 2017 |
| The first tissue-engineered airway transplantation: 5-year follow-up results A Gonfiotti, MO Jaus, D Barale, S Baiguera, C Comin, F Lavorini, ... The Lancet 383 (9913), 238, 2014 | 352 | 2014 |
| Retail sales of inhalation devices in European countries: so much for a global policy F Lavorini, CJ Corrigan, PJ Barnes, PRN Dekhuijzen, ML Levy, ... Respiratory medicine 105 (7), 1099-1103, 2011 | 187 | 2011 |
| New inhaler devices-the good, the bad and the ugly F Lavorini, GA Fontana, OS Usmani Respiration 88 (1), 3-15, 2014 | 177 | 2014 |
| Defective motor control of coughing in Parkinson's disease GA Fontana, T Pantaleo, F Lavorini, F Benvenuti, S Gangemi American journal of respiratory and critical care medicine 158 (2), 458-464, 1998 | 177 | 1998 |
| Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting JAM Westerik, V Carter, H Chrystyn, A Burden, SL Thompson, D Ryan, ... Journal of Asthma 53 (3), 321-329, 2016 | 135 | 2016 |
| The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes S Bosnic-Anticevich, H Chrystyn, RW Costello, MB Dolovich, MJ Fletcher, ... International journal of chronic obstructive pulmonary disease, 59-71, 2016 | 130 | 2016 |
| The challenge of delivering therapeutic aerosols to asthma patients F Lavorini International Scholarly Research Notices 2013, 2013 | 130 | 2013 |
| The ADMIT series-issues in inhalation therapy. 6) Training tools for inhalation devices F Lavorini, ML Levy, C Corrigan, G Crompton Primary Care Respiratory Journal 19 (4), 335-341, 2010 | 130 | 2010 |
| Cough motor mechanisms GA Fontana, F Lavorini Respiratory physiology & neurobiology 152 (3), 266-281, 2006 | 125 | 2006 |
| Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach PNR Dekhuijzen, W Vincken, JC Virchow, N Roche, A Agusti, F Lavorini, ... Respiratory medicine 107 (12), 1817-1821, 2013 | 123 | 2013 |
| Targeting drugs to the airways: the role of spacer devices F Lavorini, GA Fontana Expert opinion on drug delivery 6 (1), 91-102, 2009 | 120 | 2009 |
| Identification of a predominant COPD phenotype in clinical practice M Pistolesi, G Camiciottoli, M Paoletti, C Marmai, F Lavorini, E Meoni, ... Respiratory medicine 102 (3), 367-376, 2008 | 116 | 2008 |
| Recent advances in capsule-based dry powder inhaler technology F Lavorini, M Pistolesi, OS Usmani Multidisciplinary respiratory medicine 12, 1-7, 2017 | 114 | 2017 |
| Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) ML Levy, PNR Dekhuijzen, PJ Barnes, M Broeders, CJ Corrigan, ... NPJ primary care respiratory medicine 26 (1), 1-7, 2016 | 111 | 2016 |
| Understanding dry powder inhalers: key technical and patient preference attributes ML Levy, W Carroll, JL Izquierdo Alonso, C Keller, F Lavorini, L Lehtimäki Advances in therapy 36 (10), 2547-2557, 2019 | 85 | 2019 |
| Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab G Meoni, V Ghini, L Maggi, A Vignoli, A Mazzoni, L Salvati, M Capone, ... PLoS Pathogens 17 (2), e1009243, 2021 | 84 | 2021 |
